FDA clears drug used to treat depression for chronic musculoskeletal pain – Ortho SuperSite
The FDA recently approved duloxetine hydrochloride to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain, according to an FDA press release.
View original post here:
FDA clears drug used to treat depression for chronic musculoskeletal pain – Ortho SuperSite
FDA panel backs wider use of Eli Lilly’s Cymbalta – CNN Money
BETHESDA, Md. (Reuters) – Eli Lilly and Co’s antidepressant Cymbalta should be approved to help ease chronic pain in certain patients, a U.S
Go here to see the original:
FDA panel backs wider use of Eli Lilly’s Cymbalta – CNN Money
FDA panel mixed on approving Cymbalta for pain – AP – msnbc.com
A majority of federal health advisers say a best-selling antidepressant from Eli Lilly & Co. appears effective in treating back pain, but not arthritis. The Food and Drug Administration is considering whether to broaden …
Go here to see the original:
FDA panel mixed on approving Cymbalta for pain – AP – msnbc.com
FDA cancels meeting to review Lilly’s antidepressant as a new pain treatment (Minneapolis-St. Paul Star Tribune)
WASHINGTON – The Food and Drug Administration has canceled a meeting to review Eli Lilly’s antidepressant Cymbalta for a new use against chronic pain.
Read this article:
FDA cancels meeting to review Lilly’s antidepressant as a new pain treatment (Minneapolis-St. Paul Star Tribune)